Start Date
July 31, 1998
Study Completion Date
April 30, 2004
irinotecan hydrochloride
University of Pennsylvania Cancer Center, Philadelphia
Johns Hopkins Oncology Center, Baltimore
Emory University Hospital - Atlanta, Atlanta
H. Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama Comprehensive Cancer Center, Birmingham
Henry Ford Hospital, Detroit
Massachusetts General Hospital Cancer Center, Boston
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem
University of Texas Health Science Center at San Antonio, San Antonio
National Cancer Institute (NCI)
NIH
New Approaches to Brain Tumor Therapy Consortium
OTHER